Detalhe da pesquisa
1.
Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies.
Nat Immunol
; 23(6): 904-915, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618834
2.
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis.
Immunity
; 56(11): 2555-2569.e5, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967531
3.
Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer.
Immunity
; 55(11): 2044-2058.e5, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36288724
4.
Author Correction: Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies.
Nat Immunol
; 23(8): 1285, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705800
5.
Reprogramming tumour-associated macrophages to outcompete cancer cells.
Nature
; 619(7970): 616-623, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380769
6.
Programme of self-reactive innate-like T cell-mediated cancer immunity.
Nature
; 605(7908): 139-145, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444279
7.
Satb1: Restraining PD1 and T Cell Exhaustion.
Immunity
; 46(1): 3-5, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28099863
8.
Cancer immunotherapy via targeted TGF-ß signalling blockade in TH cells.
Nature
; 587(7832): 121-125, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087933
9.
TGF-ß suppresses type 2 immunity to cancer.
Nature
; 587(7832): 115-120, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087928
10.
Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.
J Immunol
; 200(2): 408-414, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311382
11.
Foxp3-independent mechanism by which TGF-ß controls peripheral T cell tolerance.
Proc Natl Acad Sci U S A
; 114(36): E7536-E7544, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827353
12.
Assessing lineage and cytolytic functional potential of murine tissue-resident innate lymphocytes.
STAR Protoc
; 4(1): 102136, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861825
13.
Assessing in vivo presentation of exogenous antigen in the tumor microenvironment in mice.
STAR Protoc
; 4(2): 102185, 2023 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952337
14.
TGFß control of immune responses in cancer: a holistic immuno-oncology perspective.
Nat Rev Immunol
; 23(6): 346-362, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380023
15.
Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity.
Sci Immunol
; 7(70): eabi8642, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394814
16.
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses.
J Clin Invest
; 132(17)2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852856
17.
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.
Cancer Discov
; 12(10): 2308-2329, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758895
18.
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.
Cancer Cell
; 39(5): 662-677.e6, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33861994
19.
Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance.
J Exp Med
; 217(1)2020 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31649036
20.
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial.
Cancer Discov
; 9(4): 510-525, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30622105